stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. WXXWY
    stockgist
    HomeTop MoversCompaniesConcepts
    WXXWY logo

    WuXi Biologics (Cayman) Inc.

    WXXWY
    OTC
    Healthcare
    Biotechnology
    Wuxi, CN12,575 employeeswuxibiologics.com
    —

    At A Glance

    1

    WuXi Biologics (Cayman) Inc.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees12,575
    Fundamentals

    How The Business Makes Money

    WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

    Industry Biotechnology
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Company Profile
    CIKUNKNOWN_WXXWY
    ISINUS98260N1081
    CUSIP98260N108
    AddressNo. 108, Meiliang Road, Wuxi, 214092, CN
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice